Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial | ECLINICALMEDICINE |